China Money Network
Login
Join

Chinese Biotech Firm Yingsheng Biology Gets $14M In Series C Round

  • June 5, 2019 — 11:30 CST

This Data Is Locked!

This area is available only to Subscribers.

Yingsheng Biology, a Chinese biotechnology firm that provides mass spectrometry (MS) services, announced on Wednesday that it has raised nearly RMB100 million (US$14.47 million) in... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: